Parametric imaging in the evaluation of non-steroidal anti-inflammatory drugs

The major difficulty in clinical assessment of patients with inflammatory disease, and in the evaluation of consequent anti-inflammatory drug treatment has hitherto been the impossibility of quantifying the inflammatory process. Clinical methods have proved too rough and ready, with unacceptable levels of error even with so-called objective measurements, while laboratory investigation by scintigraphy has been of only limited value since it has previously evolved around static imaging. [Continues.]